Literature DB >> 1706408

Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies.

S L Ruo1, S W Mitchell, M P Kiley, L F Roumillat, S P Fisher-Hoch, J B McCormick.   

Abstract

Monoclonal antibodies (MAbs) were produced against two African arenaviruses, Lassa virus and Mopeia virus. Competitive binding analysis of MAbs identified four antigenic sites on the nucleoprotein (NP), two on glycoprotein 1 (GP1) and six on glycoprotein 2 (GP2) of the Josiah strain of Lassa virus. 64 virus isolates from western, central and southern Africa were all consistently distinguishable by MAbs to certain epitopic sites on GP1, GP2 and NP viral proteins. Furthermore, MAbs to Lassa virus GP1 and NP uniformly distinguished viruses from the West African countries of Sierra Leone, Liberia and Guinea from those of Nigeria. GP2-directed MAbs to two African arenaviruses reacted broadly with South American arenaviruses demonstrating that an epitopic site on GP2 may be the most highly conserved antigen in the arenavirus group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706408     DOI: 10.1099/0022-1317-72-3-549

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  31 in total

1.  Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion.

Authors:  Emily L Messina; Joanne York; Jack H Nunberg
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

2.  Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Authors:  Markus H Kainulainen; Jessica R Spengler; Stephen R Welch; JoAnn D Coleman-McCray; Jessica R Harmon; Florine E M Scholte; Cynthia S Goldsmith; Stuart T Nichol; César G Albariño; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

3.  Identification of protective Lassa virus epitopes that are restricted by HLA-A2.

Authors:  Jason Botten; Jeff Alexander; Valerie Pasquetto; John Sidney; Polly Barrowman; Joey Ting; Bjoern Peters; Scott Southwood; Barbara Stewart; Maria P Rodriguez-Carreno; Bianca Mothe; J Lindsay Whitton; Alessandro Sette; Michael J Buchmeier
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.

Authors:  W W Shanaka I Rodrigo; Juan C de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.

Authors:  S Günther; P Emmerich; T Laue; O Kühle; M Asper; A Jung; T Grewing; J ter Meulen; H Schmitz
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

6.  Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Authors:  Luis M Branco; Jessica N Grove; Lina M Moses; Augustine Goba; Mohammed Fullah; Mambu Momoh; Randal J Schoepp; Daniel G Bausch; Robert F Garry
Journal:  Virol J       Date:  2010-11-09       Impact factor: 4.099

7.  Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.

Authors:  A Lundkvist; B Niklasson
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.

Authors:  S L Ruo; A Sanchez; L H Elliott; L S Brammer; J B McCormick; S P Fisher-Hoch
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

10.  Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms.

Authors:  Luis M Branco; Robert F Garry
Journal:  Virol J       Date:  2009-09-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.